Minimal residual disease-based effect and long-term outcome...

  • Main
  • 2016 / 03
  • Minimal residual disease-based effect and long-term outcome...
Annals of Oncology 2016 / 03

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Yoon, J.-H., Yhim, H.-Y., Kwak, J.-Y., Ahn, J.-S., Yang, D.-H., Lee, J.-J., Kim, S.-J., Kim, J.-S., Park, S. J., Choi, C. W., Eom, H.-S., Park, S.-K., Choi, S.-Y., Kim, S.-H., Kim, D.-W., Lee, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw123
Date:
March, 2016
File:
PDF, 1.31 MB
english, 2016
Conversion to is in progress
Conversion to is failed